AccuPath Group Co., Ltd.

Private

JiaxingHealthcare & Life Scienceshttps://www.accupathmed.com/

Last Round

Series A

Extension

Oct 25, 2023

Company Overview

AccuPath Group Co., Ltd. is a medical technology company that provides advanced materials, components, and CDMO services for interventional and implantable medical devices.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials, Smart Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

CDMOcontract development and manufacturinginterventional medical devicesmedical device componentsballoon cathetersmedical extrusion tubingNitinol componentsimplantable textilesmedical device OEMhypotubesbiocompatible materialsmedical manufacturingmedtech supply chainmedical device prototypingmedical device outsourcing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AccuPath Group Co., Ltd. Comparables

Compare AccuPath Group Co., Ltd. with similar companies based on industry and business-model similarity.

AccuPath Group Co., Ltd. comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Biomerics	86%
Cirtec Medical	78%
Confluent Medical Technologies	76%

View all Comparables

AccuPath Group Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A Extension	Oct 25, 2023
Pre-A Round	Feb 25, 2022
VC Round	Jan 8, 2021

View all Funding Rounds

Key People

Founding team and executive leadership

Zhaomin Li

CEO

Executive Team

AccuPath Group Co., Ltd. Investors

Notable investors and investment history

AccuPath Group Co., Ltd. investors
Investor	Rounds
Chengwei Capital	Series A Extension

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Nov 6, 2024
Grew 25% QoQ, from 12 to 15 employees.
Sep 11, 2024
Grew 27% QoQ, from 11 to 14 employees.

View all signals

AccuPath Group Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

AccuPath Group Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AccuPath Group Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersJiaxing

Employee Range19

Year Founded2016

Last FundingOct 25, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.